- Goldman Sachs initiated coverage on Guidewire Software Inc GWRE with a Neutral rating. The price target for Guidewire Software is set to $57. Guidewire Software shares gained 0.48 percent to close at $60.27 on Monday.
- Analysts at Macquarie initiated coverage on Royal Caribbean Cruises Ltd RCL with an Outperform rating. Royal Caribbean Cruises shares gained 0.54 percent to $74.97 in pre-market trading.
- Analysts at DA Davidson initiated coverage on Proofpoint Inc PFPT with a Neutral rating. The price target for Proofpoint is set to $80. Proofpoint shares fell 1.82 percent to close at $73.49 on Monday.
- Analysts at Macquarie initiated coverage of Carnival Corp CCL with a Neutral rating. Carnival shares gained 0.83 percent to $49.54 in pre-market trading.
- Analysts at Leerink Swann assumed SAGE Therapeutics Inc SAGE with an Outperform rating. The price target for SAGE Therapeutics is set to $68. SAGE Therapeutics shares declined 0.89 percent to close at $45.64 on Monday.
- Analysts at Argus Research initiated coverage on United Rentals, Inc. URI with a Buy rating. The price target for United Rentals is set to $90. United Rentals shares rose 0.56 percent to close at $78.93 on Monday.
- Rodman & Renshaw initiated coverage on Tecogen Inc TGEN with a Buy rating. The price target for Tecogen is set to $6. Tecogen shares dropped 3.85 percent to close at $4.00 on Monday.
- Analysts at DA Davidson initiated coverage on HubSpot Inc HUBS with a Buy rating. The price target for HubSpot is set to $76. HubSpot shares dropped 0.03 percent to close at $57.60 on Monday.
- Analysts Piper Jaffray initiated coverage on Xencor Inc XNCR with an Overweight rating. Xencor shares gained 0.37 percent to close at $24.58 on Monday.
- Brean Capital assumed Alexion Pharmaceuticals, Inc. ALXN with a Buy rating. The price target for Alexion Pharmaceuticals is set to $221. Alexion Pharmaceuticals shares slipped 0.33 percent to close at $122.14 on Monday.
Loading...
Loading...
CCLCarnival Corp
$23.030.13%
Edge Rankings
Momentum
87.54
Growth
92.84
Quality
-
Value
67.96
Price Trend
Short
Medium
Long
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Posted In:
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in